Importance of guideline adherence for unstable angina pectoris and prevention of serious cardiovascular events by conforming to guidelines  by Tobaru, Tetsuya
Journal of Cardiology 66 (2015) 99–100Editorial
Importance of guideline adherence for unstable angina pectoris and
prevention of serious cardiovascular events by conforming to guidelines
Contents lists available at ScienceDirect
Journal of Cardiology
jo u rn al h om ep age: ww w.els evier .c o m/lo c ate / j j c cKeywords:
Unstable angina
Guideline adherence
Cardiovascular eventsBreuckmann and colleagues [1] report a retrospective study in
which they examined the status of adherence to the European
Society of Cardiology (ESC) guideline on the management of
unstable angina pectoris (UAP) [2] in certiﬁed chest pain units
(CPU) in Germany, and the difference in incidence of cardiovascu-
lar events as an outcome of treatment strategy.
This report has several outstanding features. First, the study
analyzed relatively recent data of consecutive patients presenting
at 30 CPU in Germany because of chest pain between December
2008 and July 2013. Second, the diagnosis was based on that at
discharge and not the diagnosis at the emergency department;
hence, a complete diagnosis of UAP was performed. Third, the
entry of 1400 case within a short period of 5 years can only be
achieved with a multicenter study; the fact that all the cases had
a complete follow-up was an additional merit.
Focusing on analysis based on percutaneous coronary interven-
tion (PCI), the difference between Germany and Japan becomes
evident. Obviously, the indication for PCI has to be determined as for
coronary artery bypass graft surgery (CABG) [3]. As in the SYNTAX
trial, scoring the lesion morphology and using the scores to stratify
risk is an important additional element when deciding treatment
strategy [4]. In the present study, a total of 518 patients (37%)
underwent PCI. Of these, 344 patients (24.6%) underwent PCI within
the ﬁrst day of admission as early elective strategy; 19 (1.4%) of
whom underwent PCI within 2 h; and 174 patients (12.4%)
underwent PCI within 72 h of admission as later elective strategy.
Comparing to the current situation in Japan, the percentage of
patients undergoing PCI appears to be higher in Japan than in
Germany. Moreover, the duration from admission to PCI seems to be
shorter in Japan. A possible reason is that cardiac angiography is
used frequently, which provides a favorable environment for
conducting PCI. Another factor is the use of coronary computed
tomography (CT) in suspected cases of UAP, which allows the
detection of stenosis at an early stage. In addition, since the
prevalence of vasospastic angina pectoris is known to be higherDOI of original article: http://dx.doi.org/10.1016/j.jjcc.2014.11.003
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is paid to this condition in the diagnosis of UAP. When a patient
presents at the emergency department with chest pain but no other
symptoms and electrocardiographic changes, many facilities would
conduct coronary CT if UAP is suspected. Earlier detection of
stenosis may contribute to the higher PCI rate in Japan.
The objective of the study was to examine the effect of guideline
adherence on the incidence of cardiovascular events. Undertreatment
was found in 53.2% of high-risk patients. Overall guideline non-
adherence was observed in approximately two-thirds (61.8%) of the
patients. In the non-guideline-adherent patients, the frequencies of
conditions known to be coronary risk factors, such as hypertension,
hyperlipidemia, and diabetes were signiﬁcantly higher than in
guideline-adherent patients. This ﬁnding is surprising, highlighting
the glaring fact that guidelines are not adhered to in the clinical
setting. Surely, apart from the guideline, which provides the minimum
necessary knowledge, other factors may have contributed to deciding
management strategy. However, the fact that approximately two-
thirds of the patients were not treated according to the guideline
would prompt us to consider the possibility that the guideline does
not meet the needs in the clinical setting, or that the guideline cannot
be implemented even though physicians are aware of its contents.
It is unlikely that the guideline does not meet clinical needs at all;
therefore, the second possibility that the guideline cannot be applied
clinically even though the physicians are aware of the contents would
be more plausible. As a result of non-adherence to the guideline, the
rates of major adverse coronary and cerebrovascular events (MACCE),
CABG, and rehospitalization for cardiovascular reasons are increased,
as proven by the data in this study. The difference in rate of MACCE
(1.6% for adherence vs. 4.0% for non-adherence, p < 0.05), an
important outcome, is of particular concern. Although the hard end
point of death was not signiﬁcantly different, the p-value was 0.08,
and a tendency of increase is not an overstatement. Given these
signiﬁcant differences during a short observation period of 3 months,
the differences are anticipated to be ampliﬁed further in the long term.
Although the data of this study emphasize that guideline-adherent
treatment reduces cardiovascular events, other issues remain. One
difﬁcult problem is the early treatment of troponin-negative, non-ST
elevating UAP, and further studies are anticipated.
In Japan, there is no information on the frequency of adherence
to the ESC guideline or on the effect of conformation to guidelines
on cardiovascular events. Hence, the editor is keenly aware of
the importance of the present article and anticipates that by reading
this article, cardiovascular physicians in Japan will recognize the
importance of guidelines in the clinical setting. Last but not the least, reserved.
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submitting this article to Journal of Cardiology.
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